GYP significantly reduced the expression of STAT3, EGFR, TYMS and MAPK14 in tumor tissues, while cisplatin combined with GYP could further reduce the expression of STAT3, TYMS and MAPK14 in tumor tissues. Here, GYPB is linked to neoplasm.